Iman Jeddi Sells 5,625 Shares of Intuitive Surgical (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Iman Jeddi sold 5,625 shares of the firm’s stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $420.55, for a total value of $2,365,593.75. Following the completion of the transaction, the senior vice president directly owned 6,463 shares in the company, valued at $2,718,014.65. The trade was a 46.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $407.29 on Thursday. The stock has a market capitalization of $144.25 billion, a price-to-earnings ratio of 49.37, a PEG ratio of 3.21 and a beta of 1.46. The stock’s 50-day simple moving average is $449.26 and its two-hundred day simple moving average is $502.50. Intuitive Surgical, Inc. has a 52-week low of $396.68 and a 52-week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.08 by $0.42. The business had revenue of $2.77 billion for the quarter, compared to analysts’ expectations of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The business’s revenue for the quarter was up 23.0% on a year-over-year basis. During the same period last year, the firm posted $1.81 earnings per share. As a group, equities analysts forecast that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current fiscal year.

Analyst Ratings Changes

ISRG has been the topic of several research reports. Mizuho set a $525.00 target price on Intuitive Surgical and gave the stock a “neutral” rating in a research report on Monday, April 13th. JPMorgan Chase & Co. dropped their target price on Intuitive Surgical from $625.00 to $550.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. Robert W. Baird lifted their price objective on Intuitive Surgical from $575.00 to $610.00 and gave the company an “outperform” rating in a research report on Wednesday, April 22nd. Jefferies Financial Group lowered their price objective on Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating on the stock in a research report on Wednesday, April 22nd. Finally, Argus lowered their price objective on Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating on the stock in a research report on Wednesday, February 4th. Nineteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $573.63.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in ISRG. Norges Bank bought a new stake in Intuitive Surgical during the 4th quarter valued at approximately $2,856,987,000. J. Stern & Co. LLP raised its stake in Intuitive Surgical by 18,504.6% during the 4th quarter. J. Stern & Co. LLP now owns 2,127,248 shares of the medical equipment provider’s stock valued at $1,204,788,000 after purchasing an additional 2,115,814 shares during the period. Northwestern Mutual Wealth Management Co. raised its stake in Intuitive Surgical by 1,043.3% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 1,342,121 shares of the medical equipment provider’s stock valued at $760,124,000 after purchasing an additional 1,224,734 shares during the period. Arrowstreet Capital Limited Partnership raised its stake in Intuitive Surgical by 95.3% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock valued at $970,635,000 after purchasing an additional 1,027,475 shares during the period. Finally, Polen Capital Management LLC bought a new stake in Intuitive Surgical during the 4th quarter valued at approximately $477,225,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Key Headlines Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Piper Sandler reiterated its Buy rating on Intuitive Surgical, which helps support the case that Wall Street still sees upside in the company’s robotic surgery franchise. Article Title
• Positive Sentiment: Commentary highlighted Intuitive Surgical’s AI-driven digital roadmap and da Vinci 5 adoption as potential long-term growth drivers, suggesting its robotics ecosystem still has room to expand. Article Title
• Neutral Sentiment: Several articles simply noted that ISRG has been a weak performer recently and raised the question of a rebound; these pieces did not provide a fresh catalyst. Article Title
• Negative Sentiment: Deutsche Bank cut its price target on Intuitive Surgical to $366 from $440 and kept a Sell rating, reinforcing concerns that the shares may still have downside from current levels. Article Title
• Negative Sentiment: SVP Iman Jeddi sold 5,625 shares in a pre-arranged 10b5-1 transaction, which can still weigh on sentiment because it reduces insider ownership and may be viewed cautiously by investors. Article Title
• Negative Sentiment: Market coverage also said ISRG underperformed peers and the broader healthcare group, adding to the narrative that the stock has lost momentum recently. Article Title

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.